Administration of the extra virgin olive oil (EVOO) in mild cognitive impairment (MCI) patients as a therapy for preventing the progress to AD.

CONCLUSION: We demonstrated that EVOO therapy may prevent the risk of patients with MCI to progress to AD via decreasing fibrinolytic factors PAI-1 and a2 antiplasmin that reflecting in the diminution of the hallmarks proteins of AD, tau and Aβ amyloid as well and in a biomarker of oxidative stress, MDA. PMID: 31802059 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31802059?dopt=Abstract

Source: Hellenic Journal of Nuclear Medicine - December 6, 2019 Category: Nuclear Medicine Tags: Hell J Nucl Med Source Type: research